Enhanced Group (ENHA) risk factors, FY2025 10-K

Other

1. 01On October 9, 2025, the Company repaid the Note in full. The Note was terminated after the repayment
2. 02The Business Combination Agreement contains customary representations, warranties and covenants of the parties thereto. The consummation of the Enhanced Business Combination is subject to certain conditions as further described in the Business Combination Agreement
3. 03Liquidity and Capital Resources
4. 04Off-Balance Sheet Financing Arrangements
5. 05Business Combination Agreement
6. 06A Paradise Holders Support Agreement
7. 07Enhanced Holders Support Agreement
8. 08The Sponsor Equity Agreement also contains customary representations, warranties and covenants of the parties, including a lock-up on the transfer of Sponsor Securities during the option period, covenants relating to regulatory approvals and cooperation, and other customary provisions
9. 09Simple Agreements for Future Equity
10. 10Registration Rights Agreement
11. 11Critical Accounting Policies and Estimates
12. 12Class A Ordinary Shares Subject to Possible Redemption
13. 13Net Income (Loss) per Share
14. 14Recent Accounting Standards
15. 15Evaluation of Disclosure Controls and Procedures
16. 16Inherent Limitations on Effectiveness of Internal Controls
17. 17Management’s Report on Internal Controls Over Financial Reporting
18. 18Changes in Internal Control over Financial Reporting
19. 19ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
20. 20Tracy Hui Yin Choi 42 Independent Director
21. 21Number, Terms of Office and Election of Officers and Directors
22. 22Committees of the Board of Directors
23. 23The conflicts described above may not be resolved in our favor
24. 24California Board of Accountancy Regulatory Entity Member
25. 25Section 16(a) Beneficial Ownership Reporting Compliance
26. 26Executive Officers and Director Compensation
27. 27ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED SHAREHOLDER MATTERS
28. 28(3) A SPAC IV (Holdings) Corp intends to transfer (i) 20,000 shares to each of the independent non-executive directors and (ii) 25,000 shares to Kester Shing Joe Ng, our advisor, at the consummation of an initial business combination
29. 29Promissory Note — Related Party
30. 30We have not yet adopted a formal policy for the review, approval or ratification of related party transactions. Accordingly, the transactions discussed above were not reviewed, approved or ratified in accordance with any such policy
31. 31These procedures are intended to determine whether any such related party transaction impairs the independence of a director or presents a conflict of interest on the part of a director, employee or officer
32. 32ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
33. 33Item 15. Exhibits, Financial Statement Schedules
34. 34Report of Independent Registered Public Accounting Firm (PCAOB Firm # 1171) F-2
35. 35Notes to Financial Statements F-7
36. 361.1 Underwriting Agreement, dated July 29, 2025, by and between the Company and Cohen and Company Capital Markets, a division of Cohen & Company Securities, LLC (incorporated by reference to Exhibit 1.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on July 31, 2025)
37. 374.3 Specimen Right Certificate (incorporated by reference to Exhibit 4.3 to the Registration Statement on Form S-1/A filed with the Securities and Exchange Commission on June 30, 2025)
38. 384.5** Description of Securities
39. 3910.2 Investment Management Trust Agreement, dated July 29, 2025, by and between the Company and Continental Stock Transfer & Trust Company (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on July 31, 2025)
40. 4010.4 Unit Subscription Agreement, dated July 29, 2025, by and between the Company and the Sponsor (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on July 31, 2025)
41. 41104 Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit)
42. 42Opinion on the Financial Statements
43. 43Substantial Doubt about the Company’s Ability to Continue as a Going Concern
44. 44Total Assets $ 204,154,720 $ 25,217
45. 45Commitments and Contingencies (Note 6)
46. 46Preferred shares, no par value; 5,000,000 shares authorized; none issued and outstanding as of December 31, 2025 and 2024 $ — $ —
47. 47(1) All share data has been retroactively restated to reflect the Sponsor’s forfeiture of 1,000,000 founder shares on September 15, 2025 for no consideration as the underwriters of the IPO did not exercise the over-allotment option (see Note 5)
48. 48Loss from operations (1,038,358 ) (75,562 )
49. 49(1) All share and per share data has been retroactively restated to reflect the Sponsor’s forfeiture of 1,000,000 founder shares on September 15, 2025 for no consideration as the underwriters of the IPO did not exercise the over-allotment option (see Note 5)
50. 50Balance as of December 31, 2024 — $ — — $ — 6,666,667 $ — $ 25,000 $ (265,659 ) $ (240,659 )
51. 51Net income (loss) $ 2,568,594 $ (75,562 )
52. 52Gain on expiration of over-allotment option liability (272,989 ) —
53. 53Net Cash Used in Operating Activities (774,875 ) (72,892 )
54. 54Net Cash Used in Investing Activities (200,000,000 ) —
55. 55Cash, End of Year $ 697,629 $ —
56. 56Note 1 — Description of Organization and Business Operations
57. 57The Company has a wholly owned inactive subsidiary, A Paradise Merger Sub I, Inc. (the “Merger Sub”), a Cayman Islands exempted company, formed on November 18, 2025 solely for the purpose of completing the transactions contemplated by the Business Combination Agreement, dated as November 26, 2025
58. 58Going Concern Consideration
59. 59Principles of consolidation
60. 60Cash and Cash Equivalents
61. 61Concentration of Credit Risk
62. 62Offering Costs Associated with Initial Public Offering
63. 63The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets, primarily due to its short-term nature
64. 64Level 1 — Assets and liabilities with unadjusted, quoted prices listed on active market exchanges. Inputs to the fair value measurement are observable inputs, such as quoted prices in active markets for identical assets or liabilities
65. 65Investments Held in Trust Account
66. 66Gross proceeds $ 200,000,000
67. 67Net Income (Loss) per Ordinary Share
68. 68Allocation of net income (loss) 2,907,483 (338,889 ) — (75,562 )
69. 69Recent Accounting Pronouncements
70. 70Note 3 — Initial Public Offering
71. 71Note 4 — Private Placement
72. 72The underwriters had a 45-day option from the date of the IPO to purchase up to an additional 3,000,000 Units to cover over-allotments, if any, which expired unexercised on September 12, 2025
73. 73Class A Ordinary Shares — The Company is authorized to issue a total of 500,000,000 Class A ordinary shares with no par value. As of December 31, 2025 and 2024, there were 600,000 and nil Class A ordinary shares outstanding, excluding 20,000,000 and nil shares subject to possible redemption, respectively
74. 74Note 8 — Fair Value Measurements
75. 75Note 9 — Segment Information
76. 76Interest earned on investment held in Trust Account $ 3,318,154 $ —
77. 77Note 10 — Subsequent Events